The weekly litigation news digest is live. Subscribe now

Daiichi Sankyo competitive analysis

Loading summary...

Explore Daiichi Sankyo's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 4, 2025
Patent NumberPublication DateTitleTotal Oppositions
Aug 16, 2023Pharmaceutical Composition2
Oct 6, 2021Method For Improved High Secretory Production Of Proteins1
Dec 18, 2019Method For Predicting Responsiveness To Cancer Treatment Using P300-Inhibiting Compound1

Latest PTAB cases involving Daiichi Sankyo

Discover the latest PTAB cases involving Daiichi Sankyo, highlighting their recent legal challenges and patent disputes.

Last updated on: Dec 9, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Daiichi Sankyo

PGR2023-00037Jun 16, 2023ONCUSP THERAPEUTICSDAIICHI SANKYOTerminated-Settled
PGR2021-00042Jan 22, 2021DAIICHI SANKYOSEAGENTerminated-Adverse Judgment
PGR2021-00030Dec 23, 2020DAIICHI SANKYOSEAGENFinal Written Decision - Appealed
IPR2015-01881Oct 5, 2015LUPINDAIICHI SANKYOFinal Written Decision
IPR2015-01882Oct 5, 2015LUPINDAIICHI SANKYOFinal Written Decision
IPR2015-01492Jun 26, 2015PANACEA BIOTECDAIICHI SANKYOInstitution Denied
IPR2015-01496Jun 26, 2015PANACEA BIOTECDAIICHI SANKYOInstitution Denied
IPR2015-00865Mar 13, 2015ACCORD HEALTHCAREDAIICHI SANKYOFinal Written Decision
IPR2015-00864Mar 12, 2015ACCORD HEALTHCAREDAIICHI SANKYOFinal Written Decision
IPR2015-00291Nov 25, 2014DAIICHI SANKYOALETHIA BIOTHERAPEUTICSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Daiichi Sankyo with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 4, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
DAIICHI SANKYO - 437
ACCORD HEALTHCARE39 - 4 -
LUPIN - 115 -
PANACEA BIOTEC - - 2 -